Real World Evidence

The data landscape is complex and evolving rapidly. The expanding number of data types and sources, the advancement of technology-driven solutions, and the increasing demand for richer and more targeted data with therapeutic area and outcomes focus is providing new opportunities to navigate the increasingly complex path to market. We help our clients identify fit-for-purpose real world data and design studies to generate the strongest evidence to meet stakeholder needs.

Lumanity has partnered with the PHARMO Institute, an organization dedicated to developing cutting-edge solutions that support enhanced real world data analytics. The PHARMO Institute focuses on pharmaco-epidemiology, drug utilization, drug safety, and health outcomes and they have direct access to longitudinal anonymized patient level data from the Netherlands. Together, we provide unparalleled RWE expertise and access to unique, longitudinal, and clinically rich data assets. Contact us to discuss and confirm your research insight needs.

We Can Help You:

Your Data Luminaries

500+
Data sources we can query and analyze
Data Pragmatism
Data neutrality and experience to select the most fit-for-purpose data products
Methodological Rigor
Highest standards of HIPAA/GDPR compliance, research/regulator grade data, and analytics
1,100+
Staff with expertise spanning HEOR, medical communications, payer strategy, market access, clinical and regulatory strategy, commercialization, and launch excellence
Let's Talk

We would love to hear your challenge and discuss how our team of real world evidence experts can help.

Gema Parlange, Chief Commercial and Development Officer at Lumanity
Gema Parlange MBA, MEcon Chief Commercial and Development Officer, and Global Practice Lead, Real World Evidence
Read more about Gema Parlange
Anthony Guethert Chief Technology Officer
Read more about Anthony Guethert
Jonathan Kowalski, Executive VP, Head of US HEOR at Lumanity
Jonathan Kowalski Executive Vice President, Head of US HEOR
Read more about Jonathan Kowalski
Dan Simpson MS Senior Vice President, European Real World Evidence Strategy
Read more about Dan Simpson